Scancell Holdings plc (AIM:SCLP)
15.62
-0.63 (-3.88%)
May 6, 2026, 4:11 PM GMT
Scancell Holdings Revenue
Scancell Holdings had revenue of 4.71M GBP in the twelve months ending October 31, 2025. In the fiscal year ending April 30, 2025, Scancell Holdings had annual revenue of 4.71M.
Revenue
4.71M
Revenue Growth
n/a
P/S Ratio
35.80
Revenue / Employee
78.52K
Employees
60
Market Cap
168.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 4.71M | - | - |
| Apr 30, 2024 | - | - | - |
| Apr 30, 2023 | 5.27M | - | - |
| Apr 30, 2022 | - | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oxford Biomedica | 168.74M |
| hVIVO | 49.66M |
| Bioventix | 12.54M |
| PureTech Health | 3.46M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
| Faron Pharmaceuticals Oy | 1.14M |
| Avacta Group | 113.00K |
Scancell Holdings News
- 8 days ago - FDA Grants Fast Track Designation To Scancell For ISCIB1+ In Treating Advanced Melanoma - Nasdaq
- 8 days ago - Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study - GlobeNewsWire
- 3 months ago - Scancell Holdings Earnings Call Transcript: H1 2026 - Transcripts
- 3 months ago - Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma - GlobeNewsWire
- 5 months ago - Scancell Holdings Transcript: Study update - Transcripts
- 8 months ago - Scancell Holdings Earnings Call Transcript: H2 2025 - Transcripts
- 8 months ago - Scancell reports Business Update and Financial Results for the Year Ended 30 April 2025 - GlobeNewsWire
- 10 months ago - Scancell Holdings Transcript: Study update - Transcripts